Kathleen L McGuire Selected Research

sansalvamide A

2/2008	Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
9/2007	Identification of Sansalvamide a analog potent against pancreatic cancer cell lines.
5/2007	Scaffold targeting drug-resistant colon cancers.
8/2006	Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29.
3/2006	Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen L McGuire Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 11/2004
5	Colonic Neoplasms (Colon Cancer) 10/2010 - 03/2006
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 12/2016
1	Non-Muscle Invasive Bladder Neoplasms 12/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Microsatellite Instability 10/2010
1	Inflammation (Inflammations) 10/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2007
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 08/2006
1	T-Cell Leukemia (Leukemia, T Cell) 07/2005
1	Leukemia 07/2005

Drug/Important Bio-Agent (IBA)

5	sansalvamide AIBA 02/2008 - 03/2006
3	Biological ProductsIBA 10/2010 - 08/2006
2	Pharmaceutical PreparationsIBA 02/2008 - 05/2007
1	IntegrinsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Granzymes (Granzyme)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 10/2010
1	ThymidineIBA 09/2007
1	VaccinesIBA 08/2006
1	Interleukin-2 (IL2)IBA 07/2005
1	tax Gene Products (tax Gene Product)IBA 07/2005
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 11/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2016
1	Immunotherapy 01/2022
1	Intravesical Administration 12/2016